As of 4:00pm ET
| -0.021 / -4.99%|
The 1 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 0.65, with a high estimate of 0.65 and a low estimate of 0.65. The median estimate represents a +62.50% increase from the last price of 0.40.
The current consensus among 1 polled investment analysts is to Hold stock in Synta Pharmaceuticals Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.